This review is intended to reflect the recent progress on therapeutic applications of
nanomaterials in amyloid diseases. The progress on anti‐amyloid functions of various …

Self-assembly of misfolded proteins into ordered fibrillar aggregates known as amyloid
results in various human diseases. However, more and more proteins, whether in human …

Conditions including heating mode, time, temperature, pH, moisture and protein
concentration, shear, and the presence of alcohols, chaotropic/reducing agents, enzymes …

Alzheimer's disease (AD) is the fifth leading cause of death on the planet. It hallmarks the
presence of amyloid plaques and neurofibrillary tangles in geriatric patients. The condition …

Amyloidosis is the major cause of many neurodegenerative diseases, such as, Alzheimer's
and Parkinson's where the misfolding and deposition of a previously functional protein make …

The use of inorganic nanoparticles in biomedical and biotechnological applications requires
a molecular-level understanding of interactions at nano-bio interfaces, such as cell …

Protein aggregation is correlated with the onset and progression of protein misfolding
diseases (PMDs). Inhibiting the generation of toxic aggregates of misfolded proteins has …

Inorganic surfaces and nanoparticles can accelerate or inhibit the fibrillation process of
proteins and peptides, including the biomedically relevant amyloid β peptide. However, the …

Nanoparticles have great potential to be used in various biomedical applications, including
therapy or diagnosis of amyloid‐related diseases. The physical and chemical properties of …

The generation of Aβ amyloid aggregates in the form of senile plaques in the brain is one of
the pathological hallmarks of Alzheimer's disease (AD). There is no cure for AD and one of …